Selenium in thyroid disorders — essential knowledge for clinicians (original) (raw)

• Schwarz, K. & Foltz, C. M. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292–3293 (1957).
  CAS Google Scholar
• Hatfield, D. L. & Gladyshev, V. N. How selenium has altered our understanding of the genetic code. Mol. Cell Biol. 22, 3565–3576 (2002).
  CAS PubMed PubMed Central Google Scholar
• Rayman, M. P. Selenium and human health. Lancet 379, 1256–1268 (2012). This article presents an overview of the different roles of selenium in relation to human health.
  CAS PubMed Google Scholar
• Clark, L. C. et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957–1963 (1996).
  CAS PubMed Google Scholar
• Lippman, S. M. et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51 (2009).
  CAS PubMed Google Scholar
• Fan, Y. et al. Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int. J. Endocrinol. 2014, 904573 (2014).
  PubMed PubMed Central Google Scholar
• Wichman, J., Winther, K. H., Bonnema, S. J. & Hegedus, L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26, 1681–1692 (2016). This article is a systematic review of selenium supplementation trials in AIT.
  CAS PubMed Google Scholar
• Kohrle, J., Jakob, F., Contempre, B. & Dumont, J. E. Selenium, the thyroid, and the endocrine system. Endocr. Rev. 26, 944–984 (2005). This article is a comprehensive review of the roles of different selenoproteins in the endocrine system, including the thyroid.
  CAS PubMed Google Scholar
• Labunskyy, V. M., Hatfield, D. L. & Gladyshev, V. N. Selenoproteins: molecular pathways and physiological roles. Physiol. Rev. 94, 739–777 (2014).
  CAS PubMed PubMed Central Google Scholar
• Schweizer, U. & Fradejas-Villar, N. Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism. FASEB J. 30, 3669–3681 (2016).
  CAS PubMed Google Scholar
• Dumitrescu, A. M. & Refetoff, S. Inherited defects of thyroid hormone metabolism. Ann. Endocrinol. 72, 95–98 (2011).
  CAS Google Scholar
• Schmutzler, C. et al. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. 388, 1053–1059 (2007).
  CAS PubMed Google Scholar
• Schomburg, L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat. Rev. Endocrinol. 8, 160–171 (2012).
  CAS Google Scholar
• Panicker, V. et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J. Clin. Endocrinol. Metab. 94, 1623–1629 (2009).
  CAS PubMed Google Scholar
• Jo, S. et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J. Clin. Invest. 129, 230–245 (2019).
  PubMed Google Scholar
• Carlé, A., Faber, J., Steffensen, R., Laurberg, P. & Nygaard, B. Hypothyroid patients encoding combined MCT10 and DIO2 gene polymorphisms may prefer L-T3 + L-T4 combination treatment - data using a blind, randomized, clinical study. Eur. Thyroid J. 6, 143–151 (2017).
  PubMed PubMed Central Google Scholar
• Schomburg, L. & Köhrle, J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol. Nutr. Food Res. 52, 1235–1246 (2008).
  CAS PubMed Google Scholar
• Lin, J. C. et al. Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145, 508–513 (2009).
  PubMed Google Scholar
• Curran, J. E. et al. Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234–1241 (2005).
  CAS PubMed Google Scholar
• Santos, L. R. et al. A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab. 99, E719–E723 (2014). This case–control study shows increased risk of AIT with a polymorphism in the SELENOS gene. The polymorphism further increased the risk in males, suggesting sexual dimorphism.
  CAS PubMed Google Scholar
• Johnson, C. C., Fordyce, F. M. & Rayman, M. P. Symposium on ‘Geographical and geological influences on nutrition’: factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc. Nutr. Soc. 69, 119–132 (2010).
  CAS PubMed Google Scholar
• Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (National Academies Press, 2000).
• EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for selenium. EFSA J. 12, 3846 (2014).
  Google Scholar
• Rayman, M. P. Food-chain selenium and human health: emphasis on intake. Br. J. Nutr. 100, 254–268 (2008).
  CAS PubMed Google Scholar
• Rayman, M. P. The use of high-selenium yeast to raise selenium status: how does it measure up? Br. J. Nutr. 92, 557–573 (2004).
  CAS PubMed Google Scholar
• Achouba, A., Dumas, P., Ouellet, N., Lemire, M. & Ayotte, P. Plasma levels of selenium-containing proteins in Inuit adults from Nunavik. Environ. Int. 96, 8–15 (2016).
  CAS PubMed Google Scholar
• Swanson, C. A. et al. Human [74Se]selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr. 54, 917–926 (1991).
  CAS PubMed Google Scholar
• Rayman, M. P. et al. Effect of long-term selenium supplementation on mortality: results from a multiple-dose, randomised controlled trial. Free. Radic. Biol. Med. 127, 46–54 (2018). This was a randomized, controlled trial that questioned the safety of current selenium upper tolerable intake limits.
  CAS PubMed Google Scholar
• Whanger, P. D. Selenocompounds in plants and animals and their biological significance. J. Am. Coll. Nutr. 21, 223–232 (2002).
  CAS PubMed Google Scholar
• Rayman, M. P., Infante, H. G. & Sargent, M. Food-chain selenium and human health: spotlight on speciation. Br. J. Nutr. 100, 238–253 (2008).
  CAS PubMed Google Scholar
• Patterson, B. H. et al. Human selenite metabolism: a kinetic model. Am. J. Physiol. 257, R556–R567 (1989).
  CAS PubMed Google Scholar
• Fairweather-Tait, S. J., Collings, R. & Hurst, R. Selenium bioavailability: current knowledge and future research requirements. Am. J. Clin. Nutr. 91, 1484s–1491s (2010).
  CAS PubMed Google Scholar
• Francesconi, K. A. & Pannier, F. Selenium metabolites in urine: a critical overview of past work and current status. Clin. Chem. 50, 2240–2253 (2004).
  CAS PubMed Google Scholar
• Robinson, J. R., Robinson, M. F., Levander, O. A. & Thomson, C. D. Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes. Am. J. Clin. Nutr. 41, 1023–1031 (1985).
  CAS PubMed Google Scholar
• Ashton, K. et al. Methods of assessment of selenium status in humans: a systematic review. Am. J. Clin. Nutr. 89, 2025S–2039S (2009).
  CAS PubMed Google Scholar
• Rayman, M. P. et al. Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial. Br. J. Nutr. 112, 99–111 (2014).
  CAS PubMed PubMed Central Google Scholar
• Rayman, M. P., Bode, P. & Redman, C. W. Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am. J. Obstet. Gynecol. 189, 1343–1349 (2003).
  CAS PubMed Google Scholar
• Duncan, A., Talwar, D., McMillan, D. C., Stefanowicz, F. & O’Reilly, D. S. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am. J. Clin. Nutr. 95, 64–71 (2012).
  CAS PubMed Google Scholar
• Stefanowicz, F. A. et al. Erythrocyte selenium concentration as a marker of selenium status. Clin. Nutr. 32, 837–842 (2013).
  CAS PubMed Google Scholar
• European Accreditation–Eurolab–Eurochem Reference Materials Working Group. Accreditation EA-4/14 INF: The Selection and Use of Reference Materials https://european-accreditation.org/wp-content/uploads/2018/10/ea-4-14-inf-rev00-february-2003-rev.pdf (Eurachem, 2003).
• Mita, Y. et al. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nat. Commun. 8, 1658 (2017).
  PubMed PubMed Central Google Scholar
• Xia, Y., Hill, K. E., Byrne, D. W., Xu, J. & Burk, R. F. Effectiveness of selenium supplements in a low-selenium area of China. Am. J. Clin. Nutr. 81, 829–834 (2005).
  CAS PubMed Google Scholar
• Yang, G. Q. & Xia, Y. M. Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases. Biomed. Environ. Sci. 8, 187–201 (1995).
  CAS PubMed Google Scholar
• Hughes, D. J. et al. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int. J. Cancer 136, 1149–1161 (2015).
  CAS PubMed Google Scholar
• Laclaustra, M., Navas-Acien, A., Stranges, S., Ordovas, J. M. & Guallar, E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ. Health Perspect. 117, 1409–1413 (2009).
  CAS PubMed PubMed Central Google Scholar
• Burek, C. L. & Rose, N. R. Autoimmune thyroiditis and ROS. Autoimmun. Rev. 7, 530–537 (2008).
  CAS PubMed Google Scholar
• Smith, T. J. & Hegedus, L. Graves’ disease. N. Engl. J. Med. 375, 1552–1565 (2016). This comprehensive review on Graves disease includes updates on disease aetiology and pathogenesis.
  PubMed Google Scholar
• Marino, M., Dottore, G. R., Leo, M. & Marcocci, C. Mechanistic pathways of selenium in the treatment of Graves’ disease and Graves’ orbitopathy. Horm. Metab. Res. 50, 887–893 (2018).
  CAS PubMed Google Scholar
• Rotondo Dottore, G. et al. Antioxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in Graves’ orbitopathy. Thyroid 27, 271–278 (2017).
  CAS PubMed Google Scholar
• Nettore, I. C. et al. Selenium supplementation modulates apoptotic processes in thyroid follicular cells. Biofactors 43, 415–423 (2017).
  CAS PubMed Google Scholar
• Balázs, C. & Kaczur, V. Effect of selenium on HLA-DR expression of thyrocytes. Autoimmune Dis. 2012, 374635 (2012).
  PubMed PubMed Central Google Scholar
• Huang, Z., Rose, A. H. & Hoffmann, P. R. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16, 705–743 (2012).
  CAS PubMed PubMed Central Google Scholar
• Avery, J. C. & Hoffmann, P. R. Selenium, selenoproteins, and immunity. Nutrients 10, 1203 (2018). A comprehensive review on the roles of selenoproteins in the immune system.
  PubMed Central Google Scholar
• Wang, W. et al. Effects of selenium supplementation on spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. Thyroid 25, 1137–1144 (2015).
  CAS PubMed Google Scholar
• Xue, H. et al. Selenium upregulates CD4+CD25+ regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2h4 mice. Endocr. J. 57, 595–601 (2010).
  CAS PubMed Google Scholar
• McLachlan, S. M., Aliesky, H., Banuelos, B., Hee, S. S. Q. & Rapoport, B. Variable effects of dietary selenium in mice that spontaneously develop a spectrum of thyroid autoantibodies. Endocrinology 158, 3754–3764 (2017). This experimental study provided evidence that is consistent with increased risk of AIT with low selenium status.
  CAS PubMed PubMed Central Google Scholar
• Contempre, B. et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab. 73, 213–215 (1991).
  CAS PubMed Google Scholar
• Contempre, B. et al. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin. Endocrinol. 36, 579–583 (1992).
  CAS Google Scholar
• Winther, K. H. et al. Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population. Eur. J. Endocrinol. 172, 657–667 (2015).
  CAS PubMed Google Scholar
• Duffield, A. J., Thomson, C. D., Hill, K. E. & Williams, S. An estimation of selenium requirements for New Zealanders. Am. J. Clin. Nutr. 70, 896–903 (1999).
  CAS PubMed Google Scholar
• Thomson, C. D., McLachlan, S. K., Grant, A. M., Paterson, E. & Lillico, A. J. The effect of selenium on thyroid status in a population with marginal selenium and iodine status. Br. J. Nutr. 94, 962–968 (2005).
  CAS PubMed Google Scholar
• Rayman, M. P. et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am. J. Clin. Nutr. 87, 370–378 (2008).
  CAS PubMed Google Scholar
• Hansen, P. S. et al. Genetic and environmental causes of individual differences in thyroid size: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 2071–2077 (2004).
  CAS PubMed Google Scholar
• Derumeaux, H. et al. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309–315 (2003).
  CAS PubMed Google Scholar
• Rasmussen, L. B. et al. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur. J. Endocrinol. 164, 585–590 (2011).
  CAS PubMed Google Scholar
• Wu, Q. et al. Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab. 100, 4037–4047 (2015). This was a large, community-based study that confirms previously reported associations about increased risk of thyroid disease with low selenium status.
  CAS PubMed Google Scholar
• Ajjan, R. A. & Weetman, A. P. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm. Metab. Res. 47, 702–710 (2015). A review on AIT pathogenesis, which discusses the importance of selenium.
  CAS PubMed Google Scholar
• Brix, T. H., Kyvik, K. O. & Hegedus, L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85, 536–539 (2000).
  CAS PubMed Google Scholar
• Hansen, P. S., Brix, T. H., Iachine, I., Kyvik, K. O. & Hegedus, L. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. Eur. J. Endocrinol. 154, 29–38 (2006).
  CAS PubMed Google Scholar
• Brix, T. H. & Hegedus, L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. 76, 457–464 (2012).
  CAS Google Scholar
• Bulow Pedersen, I. et al. Serum selenium is low in newly diagnosed Graves’ disease: a population-based study. Clin. Endocrinol. 79, 584–590 (2013).
  Google Scholar
• Gärtner, R., Gasnier, B. C., Dietrich, J. W., Krebs, B. & Angstwurm, M. W. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687–1691 (2002).
  PubMed Google Scholar
• Gärtner, R. & Gasnier, B. C. Selenium in the treatment of autoimmune thyroiditis. Biofactors 19, 165–170 (2003).
  PubMed Google Scholar
• Duntas, L. H., Mantzou, E. & Koutras, D. A. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148, 389–393 (2003).
  CAS PubMed Google Scholar
• Turker, O., Kumanlioglu, K., Karapolat, I. & Dogan, I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 190, 151–156 (2006).
  CAS PubMed Google Scholar
• Mazokopakis, E. E. et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid 17, 609–612 (2007).
  CAS PubMed Google Scholar
• Balázs, C. The effect of selenium therapy on autoimmune thyroiditis. Orv. Hetil. 149, 1227–1232 (2008).
  PubMed Google Scholar
• Karanikas, G. et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 18, 7–12 (2008).
  CAS PubMed Google Scholar
• Kvicala, J. et al. Effect of selenium supplementation on thyroid antibodies. J. Radioanal. Nucl. Chem. 280, 275–279 (2009).
  CAS Google Scholar
• Nacamulli, D. et al. Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol. 73, 535–539 (2010).
  CAS Google Scholar
• Krysiak, R. & Okopien, B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 96, 2206–2215 (2011).
  CAS PubMed Google Scholar
• Krysiak, R. & Okopien, B. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto’s thyroiditis. Thromb. Haemost. 108, 973–980 (2012).
  CAS PubMed Google Scholar
• Bhuyan, A. K., Sarma, D. & Saikia, U. K. Selenium and the thyroid: a close-knit connection. Indian. J. Endocrinol. Metab. 16, S354–S355 (2012).
  PubMed PubMed Central Google Scholar
• Anastasilakis, A. D. et al. Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial. Int. J. Clin. Pract. 66, 378–383 (2012).
  CAS PubMed Google Scholar
• Eskes, S. A. et al. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin. Endocrinol. 80, 444–451 (2014).
  CAS Google Scholar
• de Farias, C. R. et al. A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J. Endocrinol. Invest. 38, 1065–1074 (2015).
  PubMed Google Scholar
• Pilli, T. et al. IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: comparison between two doses of selenomethionine (80 or 160 mug) versus placebo. Eur. Thyroid J. 4, 226–233 (2015).
  CAS PubMed PubMed Central Google Scholar
• Pirola, I., Gandossi, E., Agosti, B., Delbarba, A. & Cappelli, C. Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis. Endokrynol. Pol. 67, 567–571 (2016).
  CAS PubMed Google Scholar
• Esposito, D. et al. Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J. Endocrinol. Invest. 40, 83–89 (2017).
  CAS PubMed Google Scholar
• Yu, L. et al. Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis. J. Endocrinol. Invest. 40, 1243–1250 (2017).
  CAS PubMed Google Scholar
• Wang, W. et al. Decreased thyroid peroxidase antibody titer in response to selenium supplementation in autoimmune thyroiditis and the influence of a SEPP gene polymorphism: a prospective, multicenter study in China. Thyroid 28, 1674–1681 (2018).
  CAS PubMed Google Scholar
• van Zuuren, E. J., Albusta, A. Y., Fedorowicz, Z., Carter, B. & Pijl, H. Selenium supplementation for Hashimoto’s thyroiditis: summary of a Cochrane systematic review. Eur. Thyroid J. 3, 25–31 (2014).
  PubMed Google Scholar
• Toulis, K. A., Anastasilakis, A. D., Tzellos, T. G., Goulis, D. G. & Kouvelas, D. Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163–1173 (2010).
  CAS PubMed Google Scholar
• Winther, K. H., Wichman, J. E., Bonnema, S. J. & Hegedus, L. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine 55, 376–385 (2017).
  CAS PubMed Google Scholar
• Stagnaro-Green, A. Approach to the patient with postpartum thyroiditis. J. Clin. Endocrinol. Metab. 97, 334–342 (2012).
  CAS PubMed Google Scholar
• Negro, R. et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab. 92, 1263–1268 (2007).
  CAS PubMed Google Scholar
• Mao, J. et al. Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur. J. Nutr. 55, 55–61 (2016).
  CAS PubMed Google Scholar
• Mantovani, G. et al. Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the “SERENA study”, a randomized, double-blind, placebo-controlled trial. Endocrine 66, 542–550 (2019).
  CAS PubMed Google Scholar
• Brix, T. H., Kyvik, K. O., Christensen, K. & Hegedus, L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86, 930–934 (2001).
  CAS PubMed Google Scholar
• Wertenbruch, T. et al. Serum selenium levels in patients with remission and relapse of Graves’ disease. Med. Chem. 3, 281–284 (2007).
  CAS PubMed Google Scholar
• Arikan, T. A. Plasma selenium levels in first trimester pregnant women with hyperthyroidism and the relationship with thyroid hormone status. Biol. Trace Elem. Res. 167, 194–199 (2015).
  CAS PubMed Google Scholar
• Khong, J. J. et al. Serum selenium status in Graves’ disease with and without orbitopathy: a case-control study. Clin. Endocrinol. 80, 905–910 (2014).
  CAS Google Scholar
• Dehina, N., Hofmann, P. J., Behrends, T., Eckstein, A. & Schomburg, L. Lack of association between selenium status and disease severity and activity in patients with Graves’ ophthalmopathy. Eur. Thyroid J. 5, 57–64 (2016).
  CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. Role of selenium intake for risk and development of hyperthyroidism. J. Clin. Endocrinol. Metab. 104, 568–580 (2019).
  PubMed Google Scholar
• Effraimidis, G. & Wiersinga, W. M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 170, R241–R252 (2014).
  CAS PubMed Google Scholar
• Calissendorff, J., Mikulski, E., Larsen, E. H. & Moller, M. A prospective investigation of Graves’ disease and selenium: thyroid hormones, auto-antibodies and self-rated symptoms. Eur. Thyroid J. 4, 93–98 (2015).
  CAS PubMed PubMed Central Google Scholar
• Wang, L. et al. Effect of selenium supplementation on recurrent hyperthyroidism caused by Graves’ disease: a prospective pilot study. Horm. Metab. Res. 48, 559–564 (2016).
  CAS PubMed Google Scholar
• Leo, M. et al. Effects of selenium on short-term control of hyperthyroidism due to Graves’ disease treated with methimazole: results of a randomized clinical trial. J. Endocrinol. Invest. 40, 281–287 (2017).
  CAS PubMed Google Scholar
• Kahaly, G. J., Riedl, M., Konig, J., Diana, T. & Schomburg, L. Double-blind, placebo-controlled, randomized trial of selenium in Graves hyperthyroidism. J. Clin. Endocrinol. Metab. 102, 4333–4341 (2017).
  PubMed Google Scholar
• Zheng, H. et al. Effects of selenium supplementation on Graves’ disease: a systematic review and meta-analysis. Evid. Based Complement. Alternat. Med. 2018, 3763565 (2018). A meta-analysis of trials of selenium supplementation in Graves disease.
  PubMed PubMed Central Google Scholar
• Marcocci, C. et al. Selenium and the course of mild Graves’ orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011). The only study that has investigated the effects of selenium supplementation in Graves ophthalmopathy and led to introduction of selenium supplementation in Graves ophthalmopathy.
  CAS PubMed Google Scholar
• Negro, R. et al. A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur. Thyroid J. 5, 164–170 (2016).
  CAS PubMed PubMed Central Google Scholar
• Winther, K. H., Papini, E., Attanasio, R., Negro, R. & Hegedüs, L. A 2018 European Thyroid Association survey on the use of selenium supplementation in Hashimoto’s thyroiditis. Eur. Thyroid J. https://doi.org/10.1159/000504781 (2019).
  Article PubMed Google Scholar
• Negro, R., Hegedus, L., Attanasio, R., Papini, E. & Winther, K. H. A 2018 European Thyroid Association survey on the use of selenium supplementation in Graves’ hyperthyroidism and Graves’ orbitopathy. Eur. Thyroid J. 8, 7–15 (2019).
  PubMed Google Scholar
• Pearce, S. H. et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2, 215–228 (2013).
  CAS PubMed PubMed Central Google Scholar
• Jonklaas, J. et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24, 1670–1751 (2014).
  PubMed PubMed Central Google Scholar
• Lazarus, J. et al. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur. Thyroid J. 3, 76–94 (2014).
  CAS PubMed PubMed Central Google Scholar
• Alexander, E. K. et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27, 315–389 (2017).
  PubMed Google Scholar
• Kahaly, G. J. et al. 2018 European Thyroid Association guideline for the management of Graves’ hyperthyroidism. Eur. Thyroid J. 7, 167–186 (2018).
  CAS PubMed PubMed Central Google Scholar
• Ross, D. S. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421 (2016).
  PubMed Google Scholar
• Bartalena, L. et al. The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy guidelines for the management of Graves’ orbitopathy. Eur. Thyroid J. 5, 9–26 (2016).
  CAS PubMed PubMed Central Google Scholar
• O’Toole, D., Raisbeck, M., Case, J. C. & Whitson, T. D. Selenium-induced “blind staggers” and related myths. A commentary on the extent of historical livestock losses attributed to selenosis on western US rangelands. Vet. Pathol. 33, 104–116 (1996).
  Google Scholar
• Yang, G. Q., Wang, S. Z., Zhou, R. H. & Sun, S. Z. Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 37, 872–881 (1983).
  CAS PubMed Google Scholar
• Yang, G. & Zhou, R. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J. Trace Elem. Electrolytes Health Dis. 8, 159–165 (1994).
  CAS PubMed Google Scholar
• Kristal, A. R. et al. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J. Natl Cancer Inst. 106, djt456 (2014).
  PubMed PubMed Central Google Scholar
• Stranges, S. et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 147, 217–223 (2007).
  PubMed Google Scholar
• Duffield-Lillico, A. J. et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J. Natl Cancer Inst. 95, 1477–1481 (2003).
  CAS PubMed Google Scholar
• Kim, J. et al. Association between serum selenium level and the presence of diabetes mellitus: a meta-analysis of observational studies. Diabetes Metab. J. 43, 447–460 (2019).
  PubMed PubMed Central Google Scholar
• Kohler, L. N. et al. Selenium and type 2 diabetes: systematic review. Nutrients 10, E1924 (2018).
  PubMed Google Scholar
• Jacobs, E. T. et al. Selenium supplementation and insulin resistance in a randomized, clinical trial. BMJ Open. Diabetes Res. Care 7, e000613 (2019).
  PubMed PubMed Central Google Scholar
• Stranges, S. et al. Effect of selenium supplementation on changes in HbA1c: results from a multiple-dose, randomized controlled trial. Diabetes Obes. Metab. 21, 541–549 (2019).
  CAS PubMed Google Scholar
• Steinbrenner, H., Speckmann, B., Pinto, A. & Sies, H. High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 48, 40–45 (2011).
  CAS PubMed Google Scholar
• Speckmann, B. et al. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1α with FoxO1a and hepatocyte nuclear factor 4α transcription factors. Hepatology 48, 1998–2006 (2008).
  CAS PubMed Google Scholar
• Misu, H. et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12, 483–495 (2010).
  CAS PubMed Google Scholar
• Hellwege, J. N. et al. Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 534, 33–39 (2014).
  CAS PubMed Google Scholar
• Zhang, Q. et al. Selenium levels in community dwellers with type 2 diabetes mellitus. Biol. Trace Elem. Res. 191, 354–362 (2019).
  CAS PubMed Google Scholar
• Scientific Committee on Food & Scientific Panel on Dietetic Products, Nutrition and Allergies. Tolerable upper intake levels for vitamins and minerals. (European Food Safety Authority, 2006).
• Kipp, A. P. et al. Revised reference values for selenium intake. J. Trace Elem. Med. Biol. 32, 195–199 (2015).
  CAS PubMed Google Scholar
• Hurst, R. et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 91, 923–931 (2010).
  CAS PubMed PubMed Central Google Scholar
• Winther, K. H., Bonnema, S. J. & Hegedus, L. Is selenium supplementation in autoimmune thyroid diseases justified? Curr. Opin. Endocrinol. Diabetes Obes. 24, 348–355 (2017).
  CAS PubMed Google Scholar
• Winther, K. H. et al. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 15, 115 (2014).
  PubMed PubMed Central Google Scholar
• Watt, T. et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J. Clin. Endocrinol. Metab. 99, 3708–3717 (2014).
  CAS PubMed Google Scholar
• Watt, T. et al. Development of a short version of the Thyroid-Related Patient-Reported Outcome ThyPRO. Thyroid 25, 1069–1079 (2015).
  PubMed Google Scholar
• Winther, K. H. et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One 11, e0156925 (2016).
  PubMed PubMed Central Google Scholar
• Watt, T. et al. Selenium supplementation for patients with Graves’ hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 14, 119 (2013).
  CAS PubMed PubMed Central Google Scholar
• Seale, L. A., Ogawa-Wong, A. N. & Berry, M. J. Sexual dimorphism in selenium metabolism and selenoproteins. Free. Radic. Biol. Med. 127, 198–205 (2018). A review highlighting the importance of considering sex differences in selenium metabolism and selenoprotein action when analysing laboratory and clinical data.
  CAS PubMed PubMed Central Google Scholar
• Hybsier, S. et al. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P. Redox Biol. 11, 403–414 (2017).
  CAS PubMed Google Scholar
• Prasad, V., Gall, V. & Cifu, A. The frequency of medical reversal. Arch. Intern. Med. 171, 1675–1676 (2011).
  PubMed Google Scholar
• Rayman M. P. & Duntas L. H. in The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician (eds Luster, M., Duntas, L. H. & Wartofsky, L.) 109–126 (Springer International, 2019).